ValiRx plc (LON:VAL – Get Free Report) shares dropped 12.5% during trading on Wednesday. The stock traded as low as GBX 0.14 and last traded at GBX 0.14. 324,465,531 shares traded hands during mid-day trading, an increase of 2,572% from the average session volume of 12,142,369 shares. The stock had previously closed at GBX 0.16.
ValiRx Stock Performance
The business has a 50 day moving average price of GBX 0.14 and a two-hundred day moving average price of GBX 0.18. The company has a market cap of £1.85 million, a P/E ratio of -0.34 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last issued its earnings results on Tuesday, September 15th. The company reported GBX (0.09) earnings per share for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. As a group, research analysts expect that ValiRx plc will post -1.74 EPS for the current year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
- Synchrony Aces The Quarter As Credit Fears Fade
- Higher Rates Are Sending Investors to These 3 Dividend Kings
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
